{
    "2021-11-04": [
        [
            {
                "time": "2021-11-04",
                "original_text": "天风Morning Call·晨会集萃·20211104",
                "features": {
                    "keywords": [
                        "医药",
                        "持仓比例",
                        "历史低位",
                        "自下而上",
                        "布局"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-11",
                "original_text": "高瓴，正在抛弃医药股？",
                "features": {
                    "keywords": [
                        "高瓴资本",
                        "减仓",
                        "医药股"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-11",
                "original_text": "如果现在就是医药极度悲观的底部，未来该如何布局？",
                "features": {
                    "keywords": [
                        "医药",
                        "悲观",
                        "底部",
                        "布局"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-11",
                "original_text": "商誉高企+高瓴“跑路” 爱尔眼科三季报是否爆冷？丨解财报",
                "features": {
                    "keywords": [
                        "商誉",
                        "高瓴资本",
                        "爱尔眼科",
                        "三季报"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "眼科"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-11",
                "original_text": "2021年11月投资月报：医药持仓比例历史低位 自下而上布局2022年",
                "features": {
                    "keywords": [
                        "医药",
                        "持仓比例",
                        "历史低位",
                        "布局",
                        "2022年"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-Q3",
                "original_text": "高瓴资本三季度只减仓不加仓：安全边际、成长性重定位",
                "features": {
                    "keywords": [
                        "高瓴资本",
                        "减仓",
                        "安全边际",
                        "成长性"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}